Company intelligence / Profile preview

RNA Technologies & Therapeutics

Montreal, Quebec, Canadarnatechnologies.com ↗

Ownership: Private
Development stage: Preclinical

Overview

RNA Technologies & Therapeutics is a privately held Canadian biotech specializing in the design, optimization, production (mg to g scale), purification of nucleoside-modified mRNAs—including LNP formulations—and the development of mRNA-based technologies. The company supports clients with research programs to develop new therapies through regulatory approval stages. It is not known to have reported proprietary clinical results as it operates mainly as an enabler/CDMO in the field.

Modalities: mRNA-based drugsNucleoside-modified messenger RNALipid nanoparticle delivery therapy
Industry: Drug Discovery Services

Partnerships

Not specifically listed; collaborates with clients through contract research/manufacturing agreements.Supported by Quebec Biotechnology Innovation Centre incubation program.

Beyond the preview

Go deeper on RNA Technologies & Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA Technologies & Therapeutics.

Explore the full profile